The Value of Risk Reduction in CNS Drug Development: Use of Expected Net Present Value (eNPV) as a Model

(Greenblatt W, Gilbert P, Mallinckrodt CH, Williams JBW, Popp D, Kane J, Detke MJ)
American College of Neuropsychopharmacology 51st Annual Meeting, Hollywood FL (December 2012)

Download Poster